New hope for tough bladder cancers: immunotherapy meets chemo
Disease control
Completed
This early-stage study tested whether combining an immunotherapy drug (avelumab) with a chemotherapy drug (docetaxel) is safe and effective for people with advanced bladder cancer that has spread. The trial specifically focused on patients whose cancer didn't respond to standard …
Phase: PHASE1 • Sponsor: Yousef Zakharia • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC